U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CO3.Mg
Molecular Weight 84.3139
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAGNESITE

SMILES

[Mg++].[O-]C([O-])=O

InChI

InChIKey=ZLNQQNXFFQJAID-UHFFFAOYSA-L
InChI=1S/CH2O3.Mg/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2

HIDE SMILES / InChI
Molecular Formula Mg
Molecular Weight 24.305
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula CO3
Molecular Weight 60.0089
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/9070556

Magnesite (magnesium carbonate) is a non-toxic mineral. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients. It prevents vascular calcification in these patients. Many patients with heavily symptomatic Mitral valve prolapse syndrome have low serum magnesium, and supplementation of this ion by means of magnesium carbonate leads to improvement in most symptoms.

Approval Year

Unknown
149124
Targets

Targets

Primary TargetPharmacologyConditionPotency
Modulator
846
Magnesium-bicarbonate ATPase
2
Target ID: Magnesium-bicarbonate ATPase
Activator
1447
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Phase II
1147
Unknown

Approved Use

Unknown
Preventing
Phase II
1147
Unknown

Approved Use

Unknown
Primary
Phase II
1147
Unknown

Approved Use

Unknown
Primary
Not Provided
511
Unique Water

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Hypolipidemic activity of a natural mineral water rich in calcium, magnesium, and bicarbonate in hyperlipidemic adults.
2014
[Clinical aspects of antimicrobial therapy used in patients with urogenital infections].
2012
[The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
2011
A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women.
2010-06-28
Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation.
1997-03-15
[Magnesium or proajmaline (neogilurytmal) in treatment of recurrences of paroxysmal supraventricular tachyarrhythmias?].
1994-10
Patents

Patents

04044112
2
04260192
4
04370307
2
05073562
2
05409903
2
05927288
2
06797723
2
08152895
2
08721998
2
08785535
2
08808660
19
20110274597
2
20110280778
5

Sample Use Guides

In Vivo Use Guide
6 to 8 glasses of magnesium bicarbonate water per day (125mg/L of magnesium).
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:02:30 GMT 2025
Edited
by admin
on Mon Mar 31 20:02:30 GMT 2025
Record UNII
0IHC698356
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANHYDROUS MAGNESIUM CARBONATE
MART.  
Preferred Name English
MAGNESITE
Common Name English
ANHYDROUS MAGNESIUM CARBONATE [MART.]
Common Name English
Magnesium carbonate [WHO-DD]
Common Name English
NSC-83511
Code English
E-504(I)
Common Name English
MAGNESITE (MG(CO3))
Common Name English
INS NO.504(I)
Common Name English
MAGNESIUM CARBONATE GOLD STAR
Common Name English
MAGNESIUM CARBONATE ANHYDROUS
Common Name English
INS-504(I)
Common Name English
C.I. 77713
Code English
Classification Tree Code System Code
JECFA EVALUATION INS-504(I)
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
CODEX ALIMENTARIUS (GSFA) INS-504(I)
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
Code System Code Type Description
DAILYMED
0IHC698356
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
CAS
546-93-0
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-915-9
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
PUBCHEM
11029
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
CAS
13717-00-5
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
ALTERNATIVE
HSDB
211
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
CHEBI
31793
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
NSC
83511
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
SMS_ID
100000088910
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
EPA CompTox
DTXSID4049660
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
FDA UNII
0IHC698356
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
RXCUI
2475179
Created by admin on Mon Mar 31 20:02:30 GMT 2025 , Edited by admin on Mon Mar 31 20:02:30 GMT 2025
PRIMARY
Related Record Type Details
Structure of MAGNESIUM CARBONATE
SALT/SOLVATE -> PARENT
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966